The Valley Desk

Clinical trial reportNature medicinePublished

Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

13 of 57 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Nature medicine
Published
Subject terms
Humans; Breast Neoplasms; Cyclophosphamide; Camptothecin; Doxorubicin; Antineoplastic Combined Chemotherapy Protocols; Immunoconjugates; Neoplasm Staging; Treatment Outcome; Neoadjuvant Therapy; Adult; Aged
PubMed ID
39277671
PubMed Central ID
PMC12044543
Added to directory
Source checked

Report a correction or request removal